prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler pd-rx pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 2 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 43063-260
Product ID 43063-260_41acdd32-11a7-fe53-e063-6394a90a3623
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA072575
Listing Expiration 2026-12-31
Marketing Start 1989-02-28

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43063260
Hyphenated Format 43063-260

Supplemental Identifiers

RxCUI
312594
UPC
0343063260302
UNII
X0Z7454B90

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA072575 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-260-30)
source: ndc

Packages (1)

Ingredients (1)

prazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "41acdd32-11a7-fe53-e063-6394a90a3623", "openfda": {"upc": ["0343063260302"], "unii": ["X0Z7454B90"], "rxcui": ["312594"], "spl_set_id": ["cd52f022-ca29-4f87-8684-da63e05b3c1f"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (43063-260-30)", "package_ndc": "43063-260-30", "marketing_start_date": "20100623"}], "brand_name": "Prazosin Hydrochloride", "product_id": "43063-260_41acdd32-11a7-fe53-e063-6394a90a3623", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "43063-260", "generic_name": "prazosin hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prazosin Hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA072575", "marketing_category": "ANDA", "marketing_start_date": "19890228", "listing_expiration_date": "20261231"}